Edward Schutter

Edward Schutter

Director/Board Member bei TERRASCEND CORP.

Vermögen: 20 Mio $ am 31.03.2024

72 Jahre
Health Technology
Consumer Services
Commercial Services

Profil

Mr. Edward J.
Schutter
is an Independent Director at Establishment Labs Holdings, Inc., a Chief Executive Officer at NitroMed, Inc., a Chief Executive Officer & Director at Arbor Pharmaceuticals LLC and an Executive Director & Founding Member at Bio/Med Investor Network.
He is on the Board of Directors at Intrance Medical Systems, Inc., Terrascend Corp., Vitruvias Therapeutics, Inc., Establishment Labs SA, Establishment Labs Holdings, Inc., Arbor Pharmaceuticals LLC and Bio/Med Investor Network.
Mr. Schutter was previously employed as a President & Chief Executive Officer by Arbor Pharmaceuticals, Inc., a President & Chief Operating Officer by Sciele Pharma, Inc., a President by Sciele Pharmaceuticals, Inc., a Vice President-Global Business Development by Solvay SA, a Vice President-Global Business Development by Solvay Pharmaceuticals, Inc., a Vice President-Global Business Development by Abbott Products Operations AG, a Trustee by American Heart Association, Inc., a Chairman by Center for Global Health Innovation, Inc., a Founder by Ventrus Biosciences, Inc., and a Managing Director by XenoPort, Inc. He also served on the board at Knight Therapeutics, Inc., American Diabetes Association, Mercer University and Vensun Pharmaceuticals, Inc. He received his undergraduate degree from Mercer University, a graduate degree from Nyenrode Business Universiteit and an MBA from Kennesaw State University.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
31.03.2024 369 776 ( 1,36% ) 19 Mio $ 31.03.2024
25.03.2024 863 947 ( 0,30% ) 2 Mio $ 31.03.2024

Aktive Positionen von Edward Schutter

UnternehmenPositionBeginn
ESTABLISHMENT LABS HOLDINGS INC. Director/Board Member 01.08.2015
TERRASCEND CORP. Director/Board Member 02.11.2020
Director/Board Member 04.01.2022
Chief Executive Officer -
Director/Board Member 10.01.2018
Director/Board Member -
Director/Board Member 01.01.2016
Founder -
Alle aktiven Positionen von Edward Schutter

Ehemalige bekannte Positionen von Edward Schutter

UnternehmenPositionEnde
Chief Executive Officer 01.01.2021
░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Sehen Sie sich die Erfahrung von Edward Schutter im Detail an

Ausbildung von Edward Schutter

Nyenrode Business Universiteit Graduate Degree
Mercer University Undergraduate Degree
Kennesaw State University Masters Business Admin

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Edward Schutter im Detail an

Beziehungen

100 +

Beziehungen ersten Grades

24

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen3
SOLVAY SA

Process Industries

KNIGHT THERAPEUTICS INC.

Health Technology

ESTABLISHMENT LABS HOLDINGS INC.

Health Technology

Private Unternehmen18

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Services

Health Technology

Health Technology

Commercial Services

Commercial Services

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Terrascend Corp.

Sciele Pharmaceuticals, Inc.

Health Technology

Sehen Sie sich die Unternehmensverbindungen an
  1. Börse
  2. Insiders
  3. Edward Schutter